- THIS EVENT HAS BEEN CANCELED -

Optical coherence tomography (OCT) is regarded as a standard diagnostic technique in various ophthalmology subdisciplines. However, the technology has contributed to an understanding of disease mechanisms and treatments in others disciplines including cardiology and cancer. Hear from these leading scientists and executives about their visions of the future.

2:30 PM
Introduction from the Chair

Adam Wax, CEO and Founder, Lumedica (United States); Professor, Duke University (United States); Editor-in-Chief, SPIE Optical Engineering

2:40 PM
Three Decades of Commercialization and Modern Trends in OCT Imaging

Nishant Mohan Vice President of Product Notal Vision (United States)

3:00 PM
Clinical Visible-Light OCT: What Do We Need Next?

Hao F. Zhang Professor Northwestern University (United States) Co-Founder Opticent Health (United States)

3:20 PM
Through the Curtain: OCT-Enhanced Ear Exams Remove the Guesswork

Ryan Shelton CEO PhotoniCare Inc. (United States)

3:40 PM
Portable High-Speed SSOCT for Pediatric and Point-of-Care Imaging

Hafeez Dhalla CEO Theia Imaging (United States)

4:00 PM
Improving Imaging Performance of Low-Cost OCT for the Clinic

Adam Wax CEO and Founder Lumedica (United States) Professor Duke University (United States) Editor-in-Chief SPIE Optical Engineering

4:25-5:00 PM
Panel discussion and Q&A

The twenty-minute talks are followed by a Panel Discussion and Q&A with the presenters.